Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept. [electronic resource] by
- Feltelius, N
- Fored, C M
- Blomqvist, P
- Bertilsson, L
- Geborek, P
- Jacobsson, L T
- Lindblad, S
- Lysholm, J
- Rantapää-Dahlqvist, S
- Saxne, T
- Klareskog, L
Producer: 20050224
In:
Annals of the rheumatic diseases vol. 64
Availability: No items available.
|
|
13.
|
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. [electronic resource] by
- Askling, J
- Fored, C M
- Brandt, L
- Baecklund, E
- Bertilsson, L
- Feltelius, N
- Cöster, L
- Geborek, P
- Jacobsson, L T
- Lindblad, S
- Lysholm, J
- Rantapää-Dahlqvist, S
- Saxne, T
- Klareskog, L
Producer: 20051103
In:
Annals of the rheumatic diseases vol. 64
Availability: No items available.
|
|
14.
|
Acetaminophen, aspirin, and chronic renal failure. [electronic resource] by
- Fored, C M
- Ejerblad, E
- Lindblad, P
- Fryzek, J P
- Dickman, P W
- Signorello, L B
- Lipworth, L
- Elinder, C G
- Blot, W J
- McLaughlin, J K
- Zack, M M
- Nyrén, O
Producer: 20020123
In:
The New England journal of medicine vol. 345
Availability: No items available.
|
|
15.
|
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. [electronic resource] by
- Askling, J
- Fored, C M
- Baecklund, E
- Brandt, L
- Backlin, C
- Ekbom, A
- Sundström, C
- Bertilsson, L
- Cöster, L
- Geborek, P
- Jacobsson, L T
- Lindblad, S
- Lysholm, J
- Rantapää-Dahlqvist, S
- Saxne, T
- Klareskog, L
- Feltelius, N
Producer: 20051103
In:
Annals of the rheumatic diseases vol. 64
Availability: No items available.
|